by Mathieu Ranger | 16 Sep, 2025 | Biotech Perspectives
Back to Ideas Lessons from the Sepsis Watch rollout This insightful article in the MIT Technology Review discusses the rollout of Sepsis Watch, a Duke Institute for Health Innovation deep-learning model designed to help emergency department (ED) doctors spot early...
by Mathieu Ranger | 1 Jun, 2025 | Biotech Perspectives
Back to Ideas Improving accessibility Today’s patients primarily engage with brands through online and digital resources. Although print still plays a role, especially in older and less tech-literate patient populations, marketing materials must be optimized for...
by Michelle | 12 Mar, 2025 | Biotech Perspectives
Back to Ideas The participation problem: addressing socioeconomic barriers in clinical trials Sponsors of late-stage clinical trials face a clear mandate from the FDA: they must assess safety and efficacy in populations that actually reflect the real world. Yet,...
by Mathieu Ranger | 3 Dec, 2024 | Biotech Perspectives
Back to Ideas Women’s representation in clinical research As a women-led company, equitable representation of women in healthcare research is especially important to us. As we strive to focus equally on women’s and men’s perspectives in our patient experience work, we...
by Mathieu Ranger | 14 Aug, 2024 | Biotech Perspectives
Back to Ideas Form design 101 Patients engaged in healthcare inevitably encounter forms — for intake, informed consent, patient support services sign-up, etc. It may feel trivial to pay attention to the experience of using and designing a form, but they’re an...
by Susan | 31 May, 2024 | Biotech Perspectives, Deconstructing Work
Back to Ideas Hybrid co-creation in pharma and biotech We did a strange thing earlier this month: we were running some co-creation workshops for a biotech client, so we flew across the continent and spent a week away from home in order to facilitate the sessions…on...
